6月12日，A、H股创新药概念开盘后纷纷走强，恒生沪深港创新药50指数截至发稿涨超1.3%，成分股中，主要权重股中国生物制药上涨13%，百济神州、三生制药涨超2%，药明康德、恒瑞医药、信达生物飘红。热门ETF中，创新药ETF天弘（517380）截至发稿涨超1%。Wind金融终端数据显示，截至6月11日收盘，创新药ETF天弘（517380）年内涨幅达29.23%，年内涨幅居Wind行业类ETF第一位...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.